AseBio highlights the main regulatory challenges faced by the Spanish biotechnology sector... 20/09/2024 Healthcare Access to innovation Innovative drugs Financing Sector-specific regulations, such as the revision of European pharmaceutical legislation, the IVDR and MDR Regulations... AseBio
Biotechnology plays a crucial role in the latest advances against Alzheimer's 21/09/2024 Healthcare Innovative drugs Personalized medicine Advanced therapies Biotechnology is behind every medication being tested and eventually approved, making its contribution the key factor... AseBio
Biotechnology plays a crucial role in the latest advances against Alzheimer's 21/09/2024 Nearly two decades ago, the first group of compounds to treat Alzheimer's disease were approved, but they do not stop... AseBio
AMSbiopharma launches an innovation plan to strengthen its position in the biopharmaceutic... 17/09/2024 Healthcare Drug discovery Innovative drugs AMSbiopharma’s Innovation Plan goes beyond improving internal processes, adopting a comprehensive approach that... Partners - AMSbiopharma
We analyze the challenges and opportunities for promoting and developing biotechnological ... 16/09/2024 Healthcare Access to innovation Innovative drugs Industrial biotechnology Financing Proposals such as improving the financing environment for disruptive innovation, startups, and expanding companies, or... AseBio
Biotechnology revolutionizes the diagnosis and treatment of lymphoma, the seventh most com... 15/09/2024 There are more than 40 types of lymphomas that can generally be grouped into two major subgroups: Hodgkin lymphoma and... AseBio
Biotechnology, at the forefront of the fight against sepsis, one of the world's most serio... 13/09/2024 Healthcare Innovative drugs The use of artificial intelligence or an innovative approach focused on measuring NLRP3 inflammasome activation in... AseBio
Biotechnology, at the forefront of the fight against sepsis, one of the world's most serio... 13/09/2024 Sepsis is a potentially life-threatening condition that occurs when the body's immune system reacts in an extreme way to... AseBio
ORYZON receives “Intention to grant” communication for patent relating to the use of vafid... 11/09/2024 Healthcare Innovative drugs The intention to grant is a formal communication from the EPO in which it indicates that the patent application has... Partners - Oryzon Genomics
IBRILATAZAR (ABTL0812) from AbilityPharma increases chemotherapy efectiveness by 40% in pa... 09/09/2024 Healthcare Innovative drugs Ibrilatazar is an oral drug with a novel mechanism of acton that induces autophagy through the inducton of ER-stress and... Partners - Ability Pharmaceuticals
